Professional
Added to YB: 2025-06-26
Pitch date: 2025-04-21
COR [neutral]
Cencora, Inc.
+6.21%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
Market Cap
$57.7B
Pitch Price
$279.16
Price Target
N/A
Dividend
0.81%
EV/EBITDA
12.47
P/E
22.72
EV/Sales
0.22
Sector
Health Care Providers and Services
Category
growth
Show full summary:
Carillon Scout Mid Cap Fund Portfolio Holding: Cencora, Inc.
COR (holding update): Pharmaceutical distributor raised guidance after accretive acquisitions, strong Rx demand. Consistent earnings compounder expected to benefit from healthcare growth, increased generic/biologic drug usage, and specialty services expansion through M&A.
Read full article (1 min)